2 recruiting, 2 terminated, 1 completed, 1 withdrawn. 5 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 2, Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Recruiting 2, Terminated 1, Withdrawn 1 |
Follow SNK01: new trials by email Literature Review of SNK01 trials Research Report on SNK01
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension Protocol to SNK01-AD01 Study SNK01 - Alzheimer Disease | Phase 2 | Recruiting | NKGen Biotech, Inc. | 30 | 2025-06-30 | 2025-11-13 |
| Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease SNK01, Placebo - Moderate Alzheimer Disease | Phase 1 / Phase 2 | Recruiting | NKGen Biotech, Inc. | 36 | 2023-11-21 | 2026-10-02 |
| Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers AFM24, SNK01 - Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | NKGen Biotech, Inc. | 11 | 2021-11-03 | 2024-03-01 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers SNK01, Trastuzumab, Cetuximab - Advanced Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | Withdrawn | NKGen Biotech, Inc. | 2021-03-01 | 2021-05-12 | |
| Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD) SNK01 - Alzheimer Disease, Neuro-Degenerative Disease | Phase 1 | Terminated | NKGen Biotech, Inc. | 10 | 2021-01-06 | 2024-03-01 |
| Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy SNK01, Avelumab, Pembrolizumab - Refractory Cancer, Metastatic Cancer | Phase 1 | Completed | NKGen Biotech, Inc. | 27 | 2019-07-15 | 2023-11-13 |
Neoplasm Metastasis (3) · Neoplasms (3) · Alzheimer Disease (2) · Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (2) · Recurrence (2) · Squamous Cell Carcinoma of Head and Neck (2) · Brain Diseases (1) · Breast Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Ovarian Neoplasms (1)
United States (4) · Canada (1) · Mexico (1)
Paul Chang, MPH (2) · Paul Y. Song, MD (1)